| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.05B | 61.97B | 57.65B | 54.83B | 51.05B | 48.65B |
| Gross Profit | 8.75B | 9.00B | 8.54B | 8.01B | 7.06B | 6.58B |
| EBITDA | 3.99B | 3.93B | 3.90B | 3.91B | 3.42B | 3.08B |
| Net Income | 1.02B | 1.70B | 997.00M | 1.17B | 103.00M | 1.08B |
Balance Sheet | ||||||
| Total Assets | 29.65B | 28.40B | 29.71B | 30.47B | 30.40B | 30.96B |
| Cash, Cash Equivalents and Short-Term Investments | 6.25B | 4.39B | 6.28B | 6.98B | 6.63B | 5.48B |
| Total Debt | 5.98B | 4.29B | 5.82B | 7.26B | 8.54B | 9.15B |
| Total Liabilities | 14.44B | 13.22B | 14.57B | 15.51B | 16.37B | 16.77B |
| Stockholders Equity | 15.20B | 15.17B | 15.13B | 14.95B | 14.03B | 14.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.59B | 1.60B | 2.01B | 2.02B | 1.71B |
| Operating Cash Flow | 0.00 | 3.37B | 3.21B | 3.67B | 2.97B | 2.59B |
| Investing Cash Flow | 0.00 | -1.80B | -1.67B | -1.70B | -940.00M | -998.00M |
| Financing Cash Flow | 0.00 | -3.46B | -2.25B | -1.62B | -879.00M | -792.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥32.65B | 12.37 | ― | 1.96% | 0.57% | 7.20% | |
68 Neutral | ¥15.40B | 10.26 | ― | 1.74% | 7.50% | 86.59% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥35.00B | 4.55 | ― | 0.80% | 12.41% | 129.01% | |
52 Neutral | ¥5.43B | 117.77 | ― | 0.84% | ― | ― | |
48 Neutral | ¥14.10B | 51.12 | ― | 1.61% | 2.00% | -44.01% | |
46 Neutral | ¥34.17B | 21.75 | ― | 1.65% | -1.17% | -95.57% |